English | 简体中文 | 繁體中文 | 한국어 | 日本語
  Press Releases
Wednesday, July 24, 2019
Global BioLife Inc.'s Naturally Modified Sugar Laetose(TM) Unveiled at Harvard Global Health Summit
Wednesday, June 12, 2019
Global BioLife's new mosquito repellent formula performs well against mosquitos in independent testing
Monday, January 28, 2019
Singapore eDevelopment subsidiary Global BioLife's 3F Antimicrobial Fragrance shows Efficacy against Tuberculosis
Wednesday, November 7, 2018
Singapore eDevelopment Subsidiary, Global BioLife, Proudly Announces Presentation of Parkinson's Research at Neuroscience 2018
Monday, June 18, 2018
Singapore eDevelopment Announces Corporate and Business Update
Thursday, May 31, 2018
Singapore Exchange-Listed Singapore eDevelopment Limited's U.S. Biomedical Subsidiary Global BioLife, Inc. Develops Low Glycemic Modified Sugar
Thursday, March 1, 2018
Singapore eDevelopment biomedical subsidiary confirms LB2 efficacy against Ebola
Wednesday, November 1, 2017
Singapore eDevelopment's Biomedical Subsidiary Confirms 100% Repellency of 3F Mosquito Fragrance
Tuesday, October 24, 2017
SGX-Listed Singapore eDevelopment's Global BioLife Inc Develops Breakthrough Modified Sugar
Tuesday, August 15, 2017
Singapore eDevelopment's Global BioLife and U.S.-based Chemia Corporation to Develop Functional Fragrances to Fight Mosquito-Borne Diseases

Copyright © 2019 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 800 291 0906 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6653 1210 | Tokyo: +81 3 6859 8575